Crossmark

Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges

Crossref DOI link: https://doi.org/10.1007/s40273-022-01141-x

Published Online: 2022-03-25

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gomes, Manuel https://orcid.org/0000-0002-1428-1232
Latimer, Nick

Soares, Marta

Dias, Sofia

Baio, Gianluca

Freemantle, Nick

Dawoud, Dalia

Wailoo, Allan

Grieve, Richard
Funding

Funding for this research was provided by:

Yorkshire Cancer Research (S406NL)
License Information

Text and Data Mining valid from 2022-03-25

Version of Record valid from 2022-03-25
More Information

Article History

Accepted: 10 March 2022

First Online: 25 March 2022

Declarations

:

: NL is supported by Yorkshire Cancer Research (Award S406NL).

: The authors have no conflicts or competing interests to declare.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below